The Soluble Isoform of CTLA-4 Correlates With Interferon-Α Activity in Systemic Lupus Erythematosus

Journal of Rheumatology- Canada

doi 10.3899/jrheum.190678

Full Text

Abstract

Available in

Date

Authors

Publisher

The Journal of Rheumatology

Related search

Immunoregulatory Soluble CTLA-4 Modifies Effector T-Cell Responses in Systemic Lupus Erythematosus

Arthritis Research & Therapy
2016English

Interferon Alpha in Systemic Lupus Erythematosus

Journal of Biomedicine and Biotechnology
2010English

Type I Interferon and Systemic Lupus Erythematosus

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2011English

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus

Clinical and Developmental Immunology
2012English

Association of Systemic Lupus Erythematosus Disease Activity Index Score With Clinical and Laboratory Parameters in Pediatric Onset Systemic Lupus Erythematosus

Pakistan Journal of Medical Sciences
Medicine
2020English

Interferon-Regulated Chemokines as Biomarkers of Systemic Lupus Erythematosus Disease Activity: A Validation Study

Arthritis & Rheumatism
2009English

Serial Follow Up of Soluble Thrombomodulin Levels in Patients With Systemic Lupus Erythematosus

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2000English

Defining Low Disease Activity in Systemic Lupus Erythematosus

Arthritis Care and Research
Rheumatology
2017English

Serum Soluble Interleukin 7 Receptor Is Strongly Associated With Lupus Nephritis in Patients With Systemic Lupus Erythematosus

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy